These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2744225)

  • 1. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
    Chi CW; Sykes D; Ip MM
    Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma.
    Chi CW; Ip MM
    J Natl Cancer Inst; 1988 Aug; 80(12):912-8. PubMed ID: 2456400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
    Wood KM; Thompson EA
    Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
    Ip MM; Shea WK; Sykes D; Young DA
    Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
    McPartland RP; Milholland RJ; Rosen F
    Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
    Davis JM; Chan AK; Thompson EA
    J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and localization of steroid-binding and nonsteroid-binding forms of the glucocorticoid receptor in the mouse P1798 lymphosarcoma.
    Rowan BG; Ip MM
    J Steroid Biochem Mol Biol; 1995 May; 52(5):437-50. PubMed ID: 7748809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
    Kaiser N; Milholland RJ; Rosen F
    Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
    Nicholson ML; Young DA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium butyrate on glucocorticoid-sensitive and -resistant P1798 lymphosarcoma.
    Chang YF; Wu LH; Liu TY; Yang JC; Chi CW
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):1-5. PubMed ID: 1312378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
    Thompson EA; Moore WM; Sawyer RH
    J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of a cell-culture line derived from lymphosarcoma P1798.
    Thompson EA
    Mol Cell Endocrinol; 1980 Feb; 17(2):95-102. PubMed ID: 6892700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
    Lucas KL; Barbour KW; Housley PR; Thompson EA
    Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
    Chan AK; Thompson EA
    J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential binding of mutant glucocorticoid receptors to the glucocorticoid response element of the tyrosine aminotransferase gene.
    Rowan BG; Ip MM
    J Steroid Biochem Mol Biol; 1996 May; 58(2):147-62. PubMed ID: 8809196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in the number of insulin binding sites between cortisol-sensitive and cortisol-resistant lymphoma P1798 cells.
    Roldán A; Stevens J; Hollander VP
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):711-5. PubMed ID: 4812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells.
    Nicholson ML; Voris BP; Young DA
    Cancer Res; 1981 Sep; 41(9 Pt 1):3530-7. PubMed ID: 6894886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
    Stevens J; Stevens YW
    Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New site-directed polyclonal antibody maps N-terminus of occluded region of the non-transformed glucocorticoid receptor oligomer to within BUGR epitope.
    Shea WK; Cowens JW; Ip MM
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):433-47. PubMed ID: 1716970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.